Stock Spotlight Archives - Page 9 of 374

ThursdayDec 26, 2024 2:43 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R)

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently received additional written guidance and a roadmap from the U.S. Food and Drug Administration’s (“FDA”) Division of Neurology 1 regarding a potential accelerated approval pathway for lead drug candidate CNM-Au8 in ALS. “The FDA guidance on a potential path to meet the regulatory standard for substantial evidence of effectiveness supporting accelerated approval came following an in-person Nov. 1 Type C meeting with…

FridayDec 20, 2024 3:48 pm

QualityStocksNewsBreaks – SportLync, Inc.’s Golf App Helps Enthusiasts ‘Stay in the Game’ All Year

SportLync provides a year-round platform for golf lovers to enjoy the sport. “Winter may bring frost and snow to your local course, but for avid golfers, the season is simply an invitation to explore. Why pack away your clubs when you can discover golf-friendly destinations and connect with fellow enthusiasts? SportLync’s GolfLync app, the ultimate social platform for golfers, makes it easier than ever to embrace year-round golf, whether you’re traveling to warmer climates or looking for winter-friendly courses near you,” reads a recent article. “This winter don’t let the cold stop you from enjoying your favorite pastime. Turn the season…

FridayDec 20, 2024 3:04 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Committed to Ensuring Highest Standards in Continued Buntanetap Trials

Annovis Bio (NYSE: ANVS) is a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases. The company’s lead candidate, buntanetap, is an innovative drug that targets multiple pathways involved in neurodegenerative diseases by inhibiting the production of neurotoxic proteins that lead to the death of neurons, thereby slowing or stopping disease progression. A recent article highlights the company’s successful clinical trials and its receipt of FDA clearance to proceed with a pivotal phase 3 Alzheimer’s disease program for buntanetap, set to begin in early 2025. “Our priority is to bring a safe and effective treatment to patients, and we are…

FridayDec 20, 2024 2:08 pm

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Highlights ‘Pervasive Nature of Mineralizing Process at Storm’

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded mineral exploration company exploring for high-grade critical and precious metal deposits, recently released an update on its Storm Copper Project, located on Somerset Island, Nunavut. According to to a recent article featuring the company, the 2024 deep-drilling campaign intends to test key geological targets at Storm as well as the potential for new zones of copper mineralization at the Deep Copper Horizon location, which was discovered in 2023. “It is encouraging to receive confirmation of our geological model with the drill bit,” Aston Bay CEO Thomas Ullrich was quoted as saying.…

ThursdayDec 19, 2024 3:31 pm

QualityStocksNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Poised for Growth in Providing Critical Resources for AI Infrastructure

McEwen Mining (NYSE: MUX) (TSX: MUX) was featured in a recent article that discussed the transformation of a nearly 150-year old Japanese firm into the country’s hottest stock amid burgeoning growth in the AI sector. “The current boom in AI has turned a previously little-known Japanese company into a star on the stock market. Fujikura, which has been in existence for the past 139 years, has shot to fame because of its longstanding excellence in making cables for data centers. Since the beginning of this year, the shares of this company have seen a whopping 400% rise in value,” the article…

WednesdayDec 18, 2024 2:34 pm

QualityStocksNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Complements Efforts to Advance Parbec Through Key Initiatives

Renforth Resources (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR), an active mineral-exploration company, is engaged in the exploration and development of the company’s wholly owned multicommodity mineral properties in Canada. Renforth previously announced its efforts to advance the knowledge of the Parbec project through several initiatives, including stripping permits and a comprehensive geochemical analysis program. “The company noted that the permit program was designed to complement its consistent efforts to advance the Parbec project, potentially leading to a more comprehensive understanding of the deposit’s near-surface gold potential and guiding future exploration and development strategies,” reads a recent article. “The geochemical analysis…

WednesdayDec 18, 2024 1:39 pm

QualityStocksNewsBreaks – Why Thumzup Media Corp. (NASDAQ: TZUP) Is ‘One to Watch’

Thumzup (NASDAQ: TZUP) is at the forefront of modernizing the marketing industry with its unique platform designed to connect advertisers directly with everyday social media users. “The company’s mission is to empower individuals by turning their authentic social media activity into a monetizable asset while providing brands with cost-effective and impactful advertising solutions,” reads a recent article. “Through its flagship Thumzup platform, the company offers a seamless system where users post about participating advertisers and receive cash payments via Venmo or PayPal. Thumzup recently announced plans to integrate bitcoin as an additional payment option, expanding accessibility for gig economy workers.” To…

TuesdayDec 17, 2024 1:52 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Delivering End-to-End Solution for EM Programs

SuperCom (NASDAQ: SPCB) is an electronic monitoring (“EM”) innovator bringing advanced technology and monitoring services to government clients for increased use in supervised-release programs. The company’s president and CEO, Ordan Trabelsi, outlined SuperCom’s services and critical benefits during a recent investor presentation at the annual LD Micro Invitational. During the event, Trabelsi explained the competitive edge of the company’s GPS-enabled PureSecurity platform, among a narrow field of rivals. “SuperCom’s end-to-end solution provides a developed GPS technology for reliable offender tracking and 24/7 monitoring services to give criminal justice clients the confidence they need to operate supervised-release programs that allow select individuals…

MondayDec 16, 2024 3:07 pm

QualityStocksNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Leveraging Innovation to Advance High-Potential Targets

Torr Metals Inc. (TSX.V: TMET) is distinguishing itself in Canada’s mining sector, presenting a compelling case for exploration-focused investors. “Torr Metals has consistently demonstrated its ability to identify and advance high-potential exploration targets through innovation and a systematic approach. At Filion, the application of LiDAR technology and targeted surface sampling has uncovered new high-grade zones, establishing a foundation for inaugural drilling on undrilled gold soil anomalies grading up to 1.32 g/t Au in 2023. At Kolos, the discovery of the Sonic Zone represents a significant step forward, identifying another potential large-scale Cu-Au porphyry system alongside previously established targets,” reads a recent…

MondayDec 16, 2024 1:34 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Eyes Clear Path Forward for Buntanetap

Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, such as Alzheimer’s (“AD”) and Parkinson’s (“PD”). The company concluded the third quarter with the completion of significant milestones and a clear path forward for its lead candidate, buntanetap. “Buntanetap is an innovative drug designed to target neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein and TDP43,” reads a recent article. “This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying, positioning buntanetap as a potential breakthrough in treating neurodegenerative diseases.”…

Site Search

Company Search

Category: Stock Spotlight